aTyr Pharma Inc

IEX • Healthcare • Biotechnology • Quote as of 10/27/2026 15:59

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeIEX

Market Capitalization10.97 mln

Float93.76 mln

Earnings Date11/05/2026

Piotroski F-Score

4 / 9

Borderline

Relative Strength

1 / 100

Severely lagging

Debt / Equity

0.23

Very low leverage

Pre-Tax Margin

-32,006%

Severely loss-making

ROE

-92.33

Deeply negative

Altman Z-Score

-13.79

Deeply distressed

Key Fundamentals

EPS-0.62

ROE-92.33

RPS0.00

ROIC-424

ROA-67.29

EBITDA, mln-59.23

EV / EBITDA0.27

EV / EBIT0.27

Revenue, mln0.19

Quote Details

Last 0.122

Change -0.028 (-18.67%)

Open 0.1217

Volume 7,326,206

Turnover 893,797

Average Volume 2,041,428

Financial Ratios

Pre-Tax Profit Margin-32,006

Leverage Ratio1.43

Current Ratio5.12

Price / Book0.61

Price / Tangible Book0.61

Debt / Equity0.23

Price / Sales153

Financial Strength

Altman Z-Score-13.79

Piotroski F-Score 4 / 9

Short Ratio1.72

Short % of Float13.19

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-30.37%	1 / 100
1 Month	-58.87%	1 / 100
2 Months	-74.95%	1 / 100
6 Months	-84.63%	1 / 100
1 Year	-87.37%	4 / 100